Jesse J Swen - JoVE Visualize

Showing results (131-140 of 149) with videos related to

Pageof 15

Sort By:

Breast Cancer Research : BCR|January 8, 2016

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)Stefanie de Groot, Ayoub Charehbili, Hanneke W M van Laarhoven, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018

A Genetic Polymorphism in <i>CTLA-4</i> Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell CarcinomaXiaoyan Liu, Jesse J Swen, Meta H M Diekstra, et al.

International Journal of Antimicrobial Agents|January 15, 2023

Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trialAnette Veringa, Roger J Brüggemann, Lambert F R Span, et al.

Pharmacogenetics and Genomics|April 23, 2020

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE studyCathelijne H van der Wouden, Stefan Böhringer, Erika Cecchin, et al.

Current Drug Metabolism|February 1, 2014

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development processKelly E Caudle, Teri E Klein, James M Hoffman, et al.

European Journal of Cancer (Oxford, England : 1990)|January 8, 2022

UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patientsEmma C Hulshof, Mirjam de With, Femke M de Man, et al.

Clinical Pharmacology and Therapeutics|April 9, 2022

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical StudyMirjam de With, Jonathan Knikman, Femke M de Man, et al.

Cancers|June 24, 2022

Genome-Wide Meta-Analysis Identifies Variants in <i>DSCAM</i> and <i>PDLIM3</i> That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with SunitinibMeta H M Diekstra, Jesse J Swen, Loes F M van der Zanden, et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2014

Evidence synthesis and guideline development in genomic medicine: current status and future prospectsSheri D Schully, Tram Kim Lam, W David Dotson, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2023

Survival of Patients With Cancer With <i>DPYD</i> Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair AnalysisJonathan E Knikman, Tycho A Wilting, Marta Lopez-Yurda, et al.

Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:

Pageof 15

Breast Cancer Research : BCR|January 8, 2016

Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)Stefanie de Groot, Ayoub Charehbili, Hanneke W M van Laarhoven, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2018

A Genetic Polymorphism in <i>CTLA-4</i> Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell CarcinomaXiaoyan Liu, Jesse J Swen, Meta H M Diekstra, et al.

International Journal of Antimicrobial Agents|January 15, 2023

Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trialAnette Veringa, Roger J Brüggemann, Lambert F R Span, et al.

Pharmacogenetics and Genomics|April 23, 2020

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE studyCathelijne H van der Wouden, Stefan Böhringer, Erika Cecchin, et al.

Current Drug Metabolism|February 1, 2014

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development processKelly E Caudle, Teri E Klein, James M Hoffman, et al.

European Journal of Cancer (Oxford, England : 1990)|January 8, 2022

UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patientsEmma C Hulshof, Mirjam de With, Femke M de Man, et al.

Clinical Pharmacology and Therapeutics|April 9, 2022

Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical StudyMirjam de With, Jonathan Knikman, Femke M de Man, et al.

Cancers|June 24, 2022

Genome-Wide Meta-Analysis Identifies Variants in <i>DSCAM</i> and <i>PDLIM3</i> That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with SunitinibMeta H M Diekstra, Jesse J Swen, Loes F M van der Zanden, et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2014

Evidence synthesis and guideline development in genomic medicine: current status and future prospectsSheri D Schully, Tram Kim Lam, W David Dotson, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2023

Survival of Patients With Cancer With <i>DPYD</i> Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair AnalysisJonathan E Knikman, Tycho A Wilting, Marta Lopez-Yurda, et al.

Pageof 15